Global Cognitive and Memory Enhancer Drugs Market Analysis 2013-2018 and Forecast 2019-2024

Table of Content

1 Industry Overview

• 1.1 Cognitive and Memory Enhancer Drugs Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Cognitive and Memory Enhancer Drugs
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Cognitive and Memory Enhancer Drugs Market by Type

• 3.1 By Type
  • 3.1.1 Aricept
  • 3.1.2 Exelon
  • 3.1.3 Namenda
  • 3.1.4 Razadyne
  • 3.1.5 Provigil
  • 3.1.6 Ritalin
  • 3.1.7 Adderall
  • 3.1.8 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

• 4.1 Allergan Plc. (Company Profile, Sales Data etc.)
• 4.2 AlternaScript LLC (Company Profile, Sales Data etc.)
• 4.3 Ceretropic (Company Profile, Sales Data etc.)
• 4.4 Eisai Co (Company Profile, Sales Data etc.)
• 4.5 Johnson & Johnson (Company Profile, Sales Data etc.)
• 4.6 Novartis International AG (Company Profile, Sales Data etc.)
• 4.7 Pfizer (Company Profile, Sales Data etc.)
• 4.8 Shire Plc. (Company Profile, Sales Data etc.)
• 4.9 Takeda Pharmaceutical Company (Company Profile, Sales Data etc.)
• 4.10 Teva Pharmaceutical Industries (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Market Demand

• 6.1 Demand Situation
  • 6.1.1 Demand in Disease Treatment
  • 6.1.2 Demand in Academic Performance
  • 6.1.3 Demand in Athletic Performance
  • 6.1.4 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Cognitive and Memory Enhancer Drugs

Table Application Segment of Cognitive and Memory Enhancer Drugs

Table Global Cognitive and Memory Enhancer Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Aricept

Table Major Company List of Exelon

Table Major Company List of Namenda

Table Major Company List of Razadyne

Table Major Company List of Provigil

Table Major Company List of Ritalin

Table Major Company List of Adderall

Table Major Company List of Others

Table Global Cognitive and Memory Enhancer Drugs Market 2013-2018, by Type, in USD Million

Table Global Cognitive and Memory Enhancer Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Allergan Plc. Overview List

Table Cognitive and Memory Enhancer Drugs Business Operation of Allergan Plc. (Sales Revenue, Cost, Gross Margin)

Table AlternaScript LLC Overview List

Table Cognitive and Memory Enhancer Drugs Business Operation of AlternaScript LLC (Sales Revenue, Cost, Gross Margin)

Table Ceretropic Overview List

Table Cognitive and Memory Enhancer Drugs Business Operation of Ceretropic (Sales Revenue, Cost, Gross Margin)

Table Eisai Co Overview List

Table Cognitive and Memory Enhancer Drugs Business Operation of Eisai Co (Sales Revenue, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Cognitive and Memory Enhancer Drugs Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)

Table Novartis International AG Overview List

Table Cognitive and Memory Enhancer Drugs Business Operation of Novartis International AG (Sales Revenue, Cost, Gross Margin)

Table Pfizer Overview List

Table Cognitive and Memory Enhancer Drugs Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)

Table Shire Plc. Overview List

Table Cognitive and Memory Enhancer Drugs Business Operation of Shire Plc. (Sales Revenue, Cost, Gross Margin)

Table Takeda Pharmaceutical Company Overview List

Table Cognitive and Memory Enhancer Drugs Business Operation of Takeda Pharmaceutical Company (Sales Revenue, Cost, Gross Margin)

Table Teva Pharmaceutical Industries Overview List

Table Cognitive and Memory Enhancer Drugs Business Operation of Teva Pharmaceutical Industries (Sales Revenue, Cost, Gross Margin)

Table Global Cognitive and Memory Enhancer Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Cognitive and Memory Enhancer Drugs Sales Revenue Share, by Company, in USD Million

Table Cognitive and Memory Enhancer Drugs Demand in Disease Treatment, 2013-2018, in USD Million

Table Major Consumers in Disease Treatment

Table Cognitive and Memory Enhancer Drugs Demand in Academic Performance, 2013-2018, in USD Million

Table Major Consumers in Academic Performance

Table Cognitive and Memory Enhancer Drugs Demand in Athletic Performance, 2013-2018, in USD Million

Table Major Consumers in Athletic Performance

Table Cognitive and Memory Enhancer Drugs Demand in Others, 2013-2018, in USD Million

Table Major Consumers in Others

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Cognitive and Memory Enhancer Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Cognitive and Memory Enhancer Drugs Production 2013-2018, by Region, in USD Million

Table Global Cognitive and Memory Enhancer Drugs Market 2013-2018, by Region, in USD Million

Table Global Cognitive and Memory Enhancer Drugs Market Share 2013-2018, by Region, in USD Million

Table North America Cognitive and Memory Enhancer Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Cognitive and Memory Enhancer Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Cognitive and Memory Enhancer Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size 2013-2018, by Country, in USD Million

Table Cognitive and Memory Enhancer Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Price Factors List

List of Figures

Figure Cognitive and Memory Enhancer Drugs Industry Chain Structure

Figure Global Cognitive and Memory Enhancer Drugs Market Growth 2013-2018, by Type, in USD Million

Figure North America Cognitive and Memory Enhancer Drugs Market, by Company, in 2018

Figure Europe Cognitive and Memory Enhancer Drugs Market Market, by Company, in 2018

Figure Asia-Pacific Cognitive and Memory Enhancer Drugs Market Market, by Company, in 2018

Figure South America Cognitive and Memory Enhancer Drugs Market Market, by Company, in 2018

Figure Middle East & Africa Cognitive and Memory Enhancer Drugs Market Market, by Company, in 2018

Figure North America Cognitive and Memory Enhancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Cognitive and Memory Enhancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Cognitive and Memory Enhancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure Marketing Channels Overview